Personalized immunotherapy prolonged life in one-third of patients with pancreatic ductal adenocarcinoma.
pancreatic ductal adenocarcinoma (PDAC)
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.